pergoveris: Clinical Trials

2 trials of pergoveris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow pergoveris: new trials by email Literature Review of pergoveris trials Research Report on pergoveris

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany9392014-01-312017-08-24
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
Gonal-f®, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG) - Assisted Reproductive Techniques, Reproductive Technology, Assisted
Phase 3CompletedMerck KGaA, Darmstadt, Germany2022011-05-312021-05-28

Conditions studied

Helping Behavior (2)  ·  Infertility (1)

Sponsors

Merck KGaA, Darmstadt, Germany (2)

Countries

Germany (2)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovakia (1)  ·  United Kingdom (1)

Top investigators

Salvatore Longobardi, MD (1)

Results publications

PMID 26141305, PMID 26194884, PMID 28137754